Absence of potentiation of the skin response to intradermal bradykinin by a long-acting angiotensin converting enzyme inhibitor, trandolapril, at conventional antihypertensive dosage in human volunteers: a double-blind, randomized, cross-over, placebo-controlled trial.

Ítems similars

• Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.
  per: Ferner, R E, et al.
  Publicat: (1987)
• The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients.
  per: Ferner, R E, et al.
  Publicat: (1989)
• A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.
  per: Li Kam Wa, T C, et al.
  Publicat: (1993)
• Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection
  per: Jancso, G, et al.
  Publicat: (2004)
• Dosage of angiotensin converting enzyme inhibitors.
  per: McMurray, J.
  Publicat: (1995)